Chris Verhofstede
Overview
Explore the profile of Chris Verhofstede including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
1045
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Landeghem E, Vanden Bulcke C, Rotsaert A, Deblonde J, Verhofstede C, Nostlinger C
BMC Public Health
. 2025 Feb;
25(1):629.
PMID: 39955490
Background: A better understanding of HIV transmission dynamics is needed to further reduce the number of new HIV diagnoses in Belgium. As environmental and social context play an important role...
2.
Moretti M, Stoffels K, Van Laethem K, Verhofstede C, van den Wijngaert S, Martin C
Top Antivir Med
. 2024 Aug;
32(2):437-444.
PMID: 39141922
Limited therapeutic options are available for patients with multidrug-resistant HIV. This report describes a 38-year-old female who was perinatally infected with HIV-1 and treated with 14 different antiretroviral regimens over...
3.
Hardy J, Demecheleer E, Schauvliege M, Staelens D, Mortier V, Verhofstede C
Microbiol Spectr
. 2024 Mar;
12(4):e0387223.
PMID: 38442427
reverse transcription of full-length HIV-1 RNA extracted from the blood plasma of people living with HIV-1 remains challenging. Here, we describe the initiation of reverse transcription of plasma-derived viral RNA...
4.
De Clercq J, De Scheerder M, Mortier V, Verhofstede C, Vandecasteele S, Allard S, et al.
Front Immunol
. 2024 Jan;
14:1337316.
PMID: 38250083
Background: Despite the beneficial effects of antiretroviral therapy (ART) initiation during acute HIV infection (AHI), residual immune activation remains a hallmark of treated HIV infection. Methods: Plasma concentrations of 40...
5.
Lagatie O, Lauwers D, Singh H, Vanroye F, Stieh D, Vingerhoets J, et al.
Microbiol Spectr
. 2023 May;
11(3):e0071523.
PMID: 37222611
Vaccine-induced seroreactivity/positivity (VISR/P) poses a significant and common challenge to HIV vaccine implementation, as up to 95% of vaccine recipients may be misclassified as having HIV infection by current HIV...
6.
Van Beckhoven D, Serrien B, Montourcy M, Verhofstede C, Van den Bossche D, Libois A, et al.
BMC Infect Dis
. 2022 Dec;
22(1):901.
PMID: 36463126
Background: To gain insight into the impact of the COVID-19 pandemic and containment measures on the HIV epidemic and services, this study aims to describe HIV trends in 2020 and...
7.
Mortier V, Debaisieux L, Dessilly G, Stoffels K, Vaira D, Vancutsem E, et al.
Open Forum Infect Dis
. 2022 Jul;
9(7):ofac195.
PMID: 35794938
Background: To assess the prevalence and evolution of transmitted drug resistance (TDR) in Belgium, a total of 3708 baseline human immunodeficiency virus (HIV)-1 sequences from patients diagnosed between 2013 and...
8.
Valcke B, Vercauteren K, Padalko E, Verhofstede C, DHerde K, Willaert W
Ann Anat
. 2021 Jul;
239:151805.
PMID: 34265386
Background: Users of anatomical donors are at risk of exposure to bloodborne pathogens. This study evaluated screening algorithms for hepatitis B and C virus, human immunodeficiency virus and Treponema pallidum...
9.
De Clercq J, Rutsaert S, De Scheerder M, Verhofstede C, Callens S, Vandekerckhove L
Acta Clin Belg
. 2020 May;
77(1):168-176.
PMID: 32468932
: In the last decade, there has been increasing scientific and legislative focus on antiretroviral treatment (ART) for all people living with HIV. Especially early ART initiation, preferably during acute...
10.
Stoffels K, Vanroye F, Mortier V, Debaisieux L, Delforge M, Depypere M, et al.
J Infect Dis
. 2020 May;
222(10):1660-1669.
PMID: 32433757
This retrospective study evaluated the reactivity of 3 human immunodeficiency virus (HIV) confirmatory assays (INNO-LIA, Geenius, and MP) and 7 HIV rapid tests on samples from 2 different study populations...